These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 29948840)
1. Clinical Application of Chromosome Microarray Analysis in Han Chinese Children with Neurodevelopmental Disorders. Xu M; Ji Y; Zhang T; Jiang X; Fan Y; Geng J; Li F Neurosci Bull; 2018 Dec; 34(6):981-991. PubMed ID: 29948840 [TBL] [Abstract][Full Text] [Related]
2. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909 [TBL] [Abstract][Full Text] [Related]
3. Chromosomal Aberrations in Pediatric Patients with Developmental Delay/Intellectual Disability: A Single-Center Clinical Investigation. Hu T; Zhang Z; Wang J; Li Q; Zhu H; Lai Y; Wang H; Liu S Biomed Res Int; 2019; 2019():9352581. PubMed ID: 31781653 [TBL] [Abstract][Full Text] [Related]
4. Application of chromosome microarray analysis in patients with unexplained developmental delay/intellectual disability in South China. Wang R; Lei T; Fu F; Li R; Jing X; Yang X; Liu J; Li D; Liao C Pediatr Neonatol; 2019 Feb; 60(1):35-42. PubMed ID: 29631977 [TBL] [Abstract][Full Text] [Related]
5. Copy Number Variations in a Cohort of 420 Individuals with Neurodevelopmental Disorders From the South of Brazil. Chaves TF; Baretto N; Oliveira LF; Ocampos M; Barbato IT; Anselmi M; De Luca GR; Barbato Filho JH; Pinto LLC; Bernardi P; Maris AF Sci Rep; 2019 Nov; 9(1):17776. PubMed ID: 31780800 [TBL] [Abstract][Full Text] [Related]
6. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea. Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622 [TBL] [Abstract][Full Text] [Related]
7. Clinical Performance of an Ultrahigh Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders. Ho KS; Twede H; Vanzo R; Harward E; Hensel CH; Martin MM; Page S; Peiffer A; Mowery-Rushton P; Serrano M; Wassman ER Biomed Res Int; 2016; 2016():3284534. PubMed ID: 27975050 [TBL] [Abstract][Full Text] [Related]
8. Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders. Ho KS; Wassman ER; Baxter AL; Hensel CH; Martin MM; Prasad A; Twede H; Vanzo RJ; Butler MG Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941670 [TBL] [Abstract][Full Text] [Related]
9. Clinical utility and cost-effectiveness analysis of chromosome testing concomitant with chromosomal microarray of patients with constitutional disorders in a U.S. academic medical center. Su M; Page S; Haag M; Swisshelm K; Hennerich D; Graw S; LeRoux J; Brzeskiewicz P; Svihovec S; Bao L J Genet Couns; 2022 Apr; 31(2):364-374. PubMed ID: 34397147 [TBL] [Abstract][Full Text] [Related]
10. Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder. Shin S; Yu N; Choi JR; Jeong S; Lee KA Ann Lab Med; 2015 Sep; 35(5):510-8. PubMed ID: 26206688 [TBL] [Abstract][Full Text] [Related]
11. A cohort study of neurodevelopmental disorders and/or congenital anomalies using high resolution chromosomal microarrays in southern Brazil highlighting the significance of ASD. Chaves TF; Ocampos M; Barbato IT; de Camargo Pinto LL; de Luca GR; Barbato Filho JH; Bernardi P; Costa Netto Muniz Y; Francesca Maris A Sci Rep; 2024 Feb; 14(1):3762. PubMed ID: 38355898 [TBL] [Abstract][Full Text] [Related]
12. Chromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual Disability. Lee JS; Hwang H; Kim SY; Kim KJ; Choi JS; Woo MJ; Choi YM; Jun JK; Lim BC; Chae JH Ann Lab Med; 2018 Sep; 38(5):473-480. PubMed ID: 29797819 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic yield of the chromosomal microarray analysis in turkish patients with unexplained development delay/ıntellectual disability(ID), autism spectrum disorders and/or multiple congenital anomalies and new clinical findings. Akkus N; Cubuk PO Mol Biol Rep; 2024 Apr; 51(1):577. PubMed ID: 38664339 [TBL] [Abstract][Full Text] [Related]
14. Chromosomal Aberrations in Pediatric Patients With Moderate/Severe Developmental Delay/Intellectual Disability With Abundant Phenotypic Heterogeneities: A Single-Center Study. Wu D; Wu Y; Lan Y; Lan S; Zhong Z; Li D; Zheng Z; Wang H; Ma L Pediatr Neurol; 2023 Oct; 147():72-81. PubMed ID: 37566956 [TBL] [Abstract][Full Text] [Related]
15. Recurrent copy number variations as risk factors for autism spectrum disorders: analysis of the clinical implications. Oikonomakis V; Kosma K; Mitrakos A; Sofocleous C; Pervanidou P; Syrmou A; Pampanos A; Psoni S; Fryssira H; Kanavakis E; Kitsiou-Tzeli S; Tzetis M Clin Genet; 2016 Jun; 89(6):708-18. PubMed ID: 26777411 [TBL] [Abstract][Full Text] [Related]
16. Chromosomal microarray in postnatal diagnosis of congenital anomalies and neurodevelopmental disorders in Serbian patients. Perovic D; Damnjanovic T; Jekic B; Dusanovic-Pjevic M; Grk M; Djuranovic A; Rasic M; Novakovic I; Maksimovic N J Clin Lab Anal; 2022 Jun; 36(6):e24441. PubMed ID: 35441737 [TBL] [Abstract][Full Text] [Related]
17. Application of chromosomal microarrays in the evaluation of intellectual disability/global developmental delay patients - A study from a tertiary care genetic centre in India. Sharma P; Gupta N; Chowdhury MR; Sapra S; Ghosh M; Gulati S; Kabra M Gene; 2016 Sep; 590(1):109-19. PubMed ID: 27291820 [TBL] [Abstract][Full Text] [Related]
18. Low-pass whole genome sequencing as a cost-effective alternative to chromosomal microarray analysis for low- and middle-income countries. Mazzonetto PC; Villela D; Krepischi ACV; Pierry PM; Bonaldi A; Almeida LGD; Paula MG; Bürger MC; de Oliveira AG; Fonseca GGG; Giugliani R; Riegel-Giugliani M; Bertola D; Yamamoto GL; Passos-Bueno MR; Campos GDS; Machado ACD; Mazzeu JF; Perrone E; Zechi-Ceide RM; Kokitsu-Nakata NM; Vieira TP; Steiner CE; Gil-da-Silva-Lopes VL; Vieira DKR; Boy R; de Pina-Neto JM; Scapulatempo-Neto C; Milanezi F; Rosenberg C Am J Med Genet A; 2024 Nov; 194(11):e63802. PubMed ID: 38924610 [TBL] [Abstract][Full Text] [Related]
19. Clinical utility of exome sequencing in individuals with large homozygous regions detected by chromosomal microarray analysis. Prasad A; Sdano MA; Vanzo RJ; Mowery-Rushton PA; Serrano MA; Hensel CH; Wassman ER BMC Med Genet; 2018 Mar; 19(1):46. PubMed ID: 29554876 [TBL] [Abstract][Full Text] [Related]
20. [Application of chromosomal microarray analysis for the diagnosis of children with intellectual disability/developmental delay and a normal karytype]. Hu T; Zhu H; Zhang Z; Wang J; Liu H; Zhang X; Zhang H; Du Z; Li L; Wang H; Liu S Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Apr; 34(2):169-172. PubMed ID: 28397211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]